Crossref

1. Impact of newer direct-acting antiviral drugs based on quality-adjusted life years

- Bhavya H. Vyas

- Nishita H. Darji

- Devang A. Rana

- Kaushal Y. Vyas

- Supriya D. Malhotra

2. The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection

- Shahram Jalilian

- Seyed Mahmoud Latifi

- Manoochehr Makvandi

- Ali Teimoori

- Azarakhsh Azaran

- Mehdi Parsanahad

- Gholamabas Kayedani

3. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis

- Masoud Behzadifar

- Hasan Abolghasem Gorji

- Aziz Rezapour

- Alireza Rezvanian

- Nicola Luigi Bragazzi

- Soudabeh Vatankhah

4. Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies

- SeyedehFatemeh Mousavi

- Maryam Alavi

- Alireza Delavari

- Hossein Poustchi

- Zahra Mohammadi

- Reza Malekzadeh

5. The Estimation of Economic Burden of Hepatitis B Virus Infection in Iran

- Mehdi Mohammadzadeh

- Behnaz Fattahi

- Tayebeh Ghari

6. Socio-economic assessments of Hepatitis C Virus infection: Evidence from Vehari district of Pakistan

- Ahmed Dilshad

- Shakeel Muhammad

- Tariq Bilal

- Mahmood Tariq

7. Elimination and Control of Viral Hepatitis B and C Infections Possible With Greater Attention to High Risk Groups

- Seyed Moayed Alavian

8. The Economic Burden of Viral hepatitis C infection at various stages of the disease in District Mardan, Pakistan

- Sajjad Khan

- Misbah Nosheen

9. Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme

- Salamat Ali

- Tofeeq Ur-Rehman

- Mashhood Ali

- Sayeed Haque

- Faisal Rasheed

- Eleri Lougher

- Muhammad Sarfraz Nawaz

- Vibhu Paudyal

10. Prevalence of HBV, HCV, and HIV Infections among Patients Undergoing Hemodialysis in Fasa, Iran: A Six-Year Follow-up Study

- Seyedeh Azra Shamsdin

- Mohamad Reza Fatahi

- Ali Reza Ansari

- Ali Reza Safarpour

11. Non-healthcare costs of hepatitis C: a systematic review

- Natàlia Pascual-Argente

- Jaume Puig-Junoy

- Anna Llagostera-Punzano

12. Economic Burden of Hepatitis C Infection

- Maria Stepanova

- Zobair M. Younossi

13. Seroepidemiology of Hepatitis C Among Drug Users at a Detoxification Center in Southeast China

- Dangui Zhang

- Xubin Zhang

- Lu Xu

- D. Lorne Tyrrell

- Michael Houghton

- William Ba-Thein

14. Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran

- Hassan Karami

- Amin Ghanbarnejad

- Mitra Nowrouzpour

- Ali Mouseli

- Reihaneh Taheri Kondar

- Maryam Shirvani Shiri

- Farbod Ebadi Fard Azar

15. Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia

- Ligita Jancoriene

- Katazyna Polubenko

- Edita Kazenaite

- Arida Buivydiene

- Jolita Jakutiene

- Ieva Tolmane

- Agita Jeruma

- Daiva Radzisauskiene

- Evelina Mockiene

- Arvydas Ambrozaitis

16. Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data

- Ayla Doğrugörün

- Elif Doyuk Kartal

- Saygın Nayman Alpat

17. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review

- T. Joseph Mattingly

- Bryan L. Love

- Bilal Khokhar

18. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS)

- Fariborz Mansour-Ghanaei

- Farahnaz Joukar

- Mohammadreza Naghipour

- Soheil Hassanipour

- Sara Yeganeh

- Masood Sepehrimanesh

- Mohammad Fathalipour

19. Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North Cyprus

- Meryem Güvenir

- Emrah Guler

- Deren Oygar

- Ahmet Behlul

- Kaya Suer

20. The role of insurance providers in supporting treatment and management of hepatitis C patients

- Masoud Behzadifar

- Hasan Abolghasem Gorji

- Aziz Rezapour

- Meysam Behzadifar

- Nicola Luigi Bragazzi

21. Evaluation of Direct Acting Antivirals Efficiency in Turkish Patients with Chronic Hepatitis C Under Strict Rules

- Figen Sarıgul

- Murat Sayan

- Ulku User

- Nefise Oztoprak

22. Economic Burden of Inflammatory Bowel Disease in Shiraz, Iran

- Leila Rahmati

- Alireza Mooghali

- Seyed Mohammad Hosein Kamani

- Fatemeh Zare

- Hassan Askari

- Ali Reza Safarpour

23. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study

- Shahab Mahmoudvand

- Somayeh Shokri

- Azarakhsh Azaran

- Seyed S. Seyedian

- Manoochehr Makvandi

- Habibollah Mirzaei

- Sheida B. Sheikhrobat